Transferencia y valorización de nanotecnologías a Pymes Innovadoras de la Euroregión (Early Adopters) – Detección temprana de fibrosis

Reference: 0181_NANOEATERS_1_E / IT-007-17
Funding Entity: EP -INTERREG V A España Portugal (POCTEP) 2014-2020
Principal Investigator: Dr. África González-Fernández
Duration: 01/04/2017 – 31/12/2020

Working group:

Dr. Jezabel Varadé López
Dr. Iria Gómez Touriño (Former member)


NANOeaters is a network of Research Centers born with the aim of supporting companies in the Euroregion, in the application of value added nanotechnological solutions, for the definition of new products and / or services, susceptible of commercial exploitation, that offer effective responses to the weaknesses detected in the Research and Innovation Strategies for Smart Specialization of the Euroregion Galicia – North of Portugal.

The objective of this activity is the early detection of fibrosis.

Chronic renal failure currently affects 10% of the world population, presenting a greater incidence in adults over 60 years. In developing countries, the treatment of this deficiency is difficult because of the cost and difficulty of the diagnosis. A method of early diagnosis of fibrosis would allow to take the therapeutic measures necessary to avoid fibrosis. The main aims of the Project include:

  • Identification of early biomarkers of peritoneal fibrosis in peritoneal dialysis
  • Development of a multiplex device allowing the detection of early biomarkers related with the risk of developing peritoneal fibrosis in patients undergoing peritoneal dialysis.

Associated research lines: , .